BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7553885)

  • 1. Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
    Pignata C; Prasad KV; Hallek M; Druker B; Rudd CE; Robertson MJ; Ritz J
    Cell Immunol; 1995 Oct; 165(2):211-6. PubMed ID: 7553885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
    Pignata C; Prasad KV; Robertson MJ; Levine H; Rudd CE; Ritz J
    J Immunol; 1993 Dec; 151(12):6794-800. PubMed ID: 8258691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking of CD45 on NK cells stimulates p56lck-mediated tyrosine phosphorylation and IFN-gamma production.
    Xu X; Chong AS
    J Immunol; 1995 Dec; 155(11):5241-8. PubMed ID: 7594536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15.
    Adunyah SE; Wheeler BJ; Cooper RS
    Biochem Biophys Res Commun; 1997 Mar; 232(3):754-8. PubMed ID: 9126349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 induces activation and association of p56(lck) and MAPK in a murine TH1 clone.
    Tsuji-Takayama K; Matsumoto S; Koide K; Takeuchi M; Ikeda M; Ohta T; Kurimoto M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):126-30. PubMed ID: 9266843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 and IL-4 mediate through two distinct kinase pathways for the activation of alphaCD3-induced activated killer cells.
    Wang J; Hargrove ME; Ting CC
    Cell Immunol; 1996 Dec; 174(2):138-46. PubMed ID: 8954613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 stimulation of T lymphocytes induces sequential activation of mitogen-activated protein kinases and phosphorylation of p56lck at serine-59.
    Watts JD; Welham MJ; Kalt L; Schrader JW; Aebersold R
    J Immunol; 1993 Dec; 151(12):6862-71. PubMed ID: 8258696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway.
    Brockdorff J; Nielsen M; Kaltoft K; Mustelin T; Röpke C; Svejaard A; Geisler C; Odum N
    Eur Cytokine Netw; 2000 Jun; 11(2):225-31. PubMed ID: 10903801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
    J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo association between p56lck and MAP kinase during IL-2-mediated lymphocyte proliferation.
    Taieb J; Blanchard DA; Auffredou MT; Chaouchi N; Vazquez A
    J Immunol; 1995 Dec; 155(12):5623-30. PubMed ID: 7499846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck.
    Wen T; Zhang L; Kung SK; Molina TJ; Miller RG; Mak TW
    Eur J Immunol; 1995 Nov; 25(11):3155-9. PubMed ID: 7489757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.
    Wang KS; Ritz J; Frank DA
    J Immunol; 1999 Jan; 162(1):299-304. PubMed ID: 9886399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
    Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR
    J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.